| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Oseltamivir | FAERS: 6 | US FAERS | |
| 2 | Zanamivir | FAERS: 4 | OFFSIDES US FAERS | |
| 3 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | FAERS: 2 | US FAERS | |
| 4 | Lamotrigine | FAERS: 1 | US FAERS | |
| 5 | PCI 32765 | FAERS: 1 | US FAERS | |
| 6 | Pregabalin | FAERS: 1 | US FAERS | |
| 7 | Voriconazole | FAERS: 1 | US FAERS | |
| 8 | Cyproheptadine | OFFSIDES | ||
| 9 | Fluorouracil | OFFSIDES | ||
| 10 | Leucovorin | OFFSIDES | ||
| 11 | Oseltamivir | OFFSIDES | ||
| 12 | Piperacillin | OFFSIDES | ||
| 13 | tulobuterol | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.